Mawi DNA Technologies Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Mawi DNA Technologies's estimated annual revenue is currently $3.6M per year.(i)
  • Mawi DNA Technologies's estimated revenue per employee is $155,000

Employee Data

  • Mawi DNA Technologies has 23 Employees.(i)
  • Mawi DNA Technologies grew their employee count by -12% last year.

Mawi DNA Technologies's People

NameTitleEmail/Phone
1
CoFounderReveal Email/Phone
2
CEO & Chief Technical OfficerReveal Email/Phone
3
Quality and Operations ManagerReveal Email/Phone
4
Product Marketing ManagerReveal Email/Phone
5
Operations SupportReveal Email/Phone
6
Research Scientist IReveal Email/Phone
7
Research Associate IReveal Email/Phone
8
Senior Scientist - MicrobiomeReveal Email/Phone
9
IP and Contract SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Mawi DNA Technologies?

Mawi's non-invasive and invasive biosample collection innovative technologies are designed for room temperature transport and storage with OMICS inmind ... Less Sample More Answers! Our focus is to offer simple and easy to use tools for the collection and Stabilization of an array of biological samples from the point of collection to processing in Genomics, Proteomics and metabolomics assays, including but not limited to: Oral samples (e.g. buccal cells) - Whole Blood - Tissue - Mammalian Cells - Body fluids - Microbial samples from different sources (e.g. feces, urine, vaginal, skin, soil etc....)

keywords:N/A

N/A

Total Funding

23

Number of Employees

$3.6M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A23-12%N/A
#2
$3.4M2310%N/A
#3
$5.3M23-4%N/A
#4
$4.3M23-28%N/A
#5
$4.3M2310%N/A